Lower level of synovial fluid interferon-γ in HLA-B27-positive than in HLA-B27-negative patients with Chlamydia trachomatis reactive arthritis

Rheumatology

Volumn 42, Issue 3, 2003, Pages 461-467

  Bas, S ^b   Kvien, T K ^a   Buchs, N ^b   Fulpius, T ^b   Gabay, C ^b  

^a DIAKONHJEMMET HOSPITAL   (Norway)

^b UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Chlamydia trachomatis; Cytokines; Interferon ; Reactive arthritis; Synovial fluid

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HLA B27 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHLAMYDIA TRACHOMATIS; CHRONIC ARTHRITIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OSTEOARTHRITIS; PRIORITY JOURNAL; REACTIVE ARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, REACTIVE; ARTHRITIS, RHEUMATOID; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; HLA-B27 ANTIGEN; HUMANS; INTERFERON TYPE II; MALE; MIDDLE AGED; SYNOVIAL FLUID;

EID: 0345385014     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg163     Document Type: Article

References (46)

1. Lahesmaa R, Yssel H, Batsford S et al. Yersinia enterocolitica activates a T helper type 1-like T cell subset in reactive arthritis. J Immunol 1992;148:3079-85.
2. Schlaak J, Hermann E, Ringhoffer M et al. Predominance of Th1-type T cells in synovial fluid of patients with Yersinia-induced reactive arthritis. Eur J Immunol 1992;22:2771-6.
3. Simon AK, Seipelt E, Wu P, Wenzel B, Braun J, Sieper J. Analysis of cytokine profiles in synovial T cell clones from chlamydial reactive arthritis patients: predominance of the Th1 subset. Clin Exp Immunol 1993;94:122-6.
4. Schlaak JF, Pfers I, Meyer Zum Buschenfelde KH, Marker-Hermann E. Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies. Clin Exp Rheumatol 1996;14:155-62.
5. Kotake S, Schumacher HR Jr, Arayssi TK et al. Gamma interferon and interleukin-10 gene expression in synovial tissues from patients with early stages of Chlamydia-associated arthritis and undifferentiated oligoarthritis and from healthy volunteers. Infect Immun 1999;67:2682-6.
6. Ribbens C, Andre B, Kaye O et al. Increased synovial fluid levels of interleukin-12, sCD25 and sTNF- RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies. Eur Cytokine Netw 2000;11:669-76.
7. Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 1994;91:8562-6.
8. Yin Z, Siegert S, Neure L et al. The elevated ratio of interferon gamma-/interleukin-4-positive T cells found in synovial fluid and synovial membrane of rheumatoid arthritis patients can be changed by interleukin-4 but not by interleukin-10 or transforming growth factor beta. Rheumatology 1999;38:1058-67.
9. Yin Z, Braun J, Neure L et al. Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis. Arthritis Rheum 1997;40:1788-97.
10. Braun J, Yin Z, Spiller I et al. Low secretion of tumor necrosis factor alpha, but no other Th1 or Th2 cytokines, by peripheral blood mononoclear cells correlates with chronicity in reactive arthritis. Arthritis Rheum 1999;42:2039-44.
11. Autenrieth IB, Beer M, Bohn E, Kaufmann SH, Heesemann J. Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon. Infect Immun 1994;62:2590-9.
12. Sieper J, Braun J. Pathogenesis of spondylarthropathies. Persistent bacterial antigen, autoimmunity, or both? Arthritis Rheum 1995;38:1547-54.
13. Holland MJ, Bailey RL, Conway DJ et al. T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC): responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring. Clin Exp Immunol 1996;105:429-35.
14. Yang X, HayGlass KT, Brunham RC. Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J Immunol 1996;156:4338-44.
15. Sieper J, Braun J, Kingsley GH. Report on the Fourth International Workshop on Reactive Arthritis. Arthritis Rheum 2000;43:720-34.
16. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
17. Hart PH, Ahern MJ, Smith MD, Finlay-Jones JJ. Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Immunology 1995;84:536-42.
18. Chomarat P, Banchereau J, Miossec P. Differential effects of interleukins 10 and 4 on the production of interleukin-6 by blood and synovium monocytes in rheumatoid arthritis. Arthritis Rheum 1995;38:1046-54.
19. Macatonia SE, Doherty TM, Knight SC, O'Garra A. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J Immunol 1993;150:3755-65.
20. Scott P. IL-12: initiation cytokine for cell-mediated immunity. Science 1993;260:496-7.
21. Dinarello CA. IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999;103:11-24.
22. Mastroeni P, Clare S, Khan S et al. Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium. Infect Immun 1999;67:478-83.
23. Gracie JA, Forsey RJ, Chan WL et al. A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 1999;104:1393-401.
24. Lammas DA, Casanova JL, Kumararatne DS. Clinical consequences of defects in the IL-12-dependent interferon-gamma (IFN-gamma) pathway. Clin Exp Immunol 2000;121:417-25.
25. Akira S. The role of IL-18 in innate immunity. Curr Opin Immunol 2000;12:59-63.
26. Yamamura M, Kawashima M, Taniai M et al. Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis. Arthritis Rheum 2001;44:275-85.
27. Rich E, Hook EW 3rd, Alarcon GS, Moreland LW. Reactive arthritis in patients attending an urban sexually transmitted diseases clinic. Arthritis Rheum 1996;39:1172-7.
28. Leirisalo-Repo M. Prognosis, course of disease, and treatment of the spondyloarthropathies. Rheum Dis Clin North Am 1998;24:737-51.
29. Kaluza W, Leirisalo-Repo M, Marker-Hermann E et al. IL10.G microsatellites mark promoter haplotypes associated with protection against the development of reactive arthritis in Finnish patients. Arthritis Rheum 2001;44:1209-14.
30. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
31. Petyovka N, Lyach L, Voitenok NN. Homologous ELISA for detection of oligomeric human TNF: properties of the assay. J Immunol Methods 1995;186:161-70.
32. Ledur A, Fitting C, David B, Hamberger C, Cavaillon JM. Variable estimates of cytokine levels produced by commercial ELISA kits: results using international cytokine standards. J Immunol Methods 1995;186:171-9.
33. Paasch BD, Reed BR, Keck R, Sandlund BK, Gilkerson E, Shalaby R. An evaluation of the accuracy of four ELISA methods for measuring natural and recombinant human interferon-γ. J Immunol Methods 1996;198:165-76.
34. Jeffes EW 3rd, Ininns EK, Schmitz KL, Yamamoto RS, Dett CA, Granger GA. The presence of antibodies to lymphotoxin and tumor necrosis factor in normal serum. Arthritis Rheum 1989;32:1148-52.
35. Cannon JG, Nerad JL, Poutsiaka DD, Dinarello CA. Measuring circulating cytokines. J Appl Physiol 1993;75:1897-902.
36. Mohler KM, Torrance DS, Smith CA et al. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 1993;151:1548-61.
37. Svenson M, Hansen MB, Bendtzen K. Binding of cytokines to pharmaceutically prepared human immuno-globulin. J Clin Invest 1993;92:2533-9.
38. James K, Milne I, Cunningham A, Elliott SF. The effect of alpha 2 macroglobulin in commercial cytokine assays. J Immunol Methods 1994;168:33-7.
39. Thiel A, Wu P, Lauster R, Braun J, Radbruch A, Sieper J. Analysis of the antigen-specific T cell response in reactive arthritis by flow cytometry. Arthritis Rheum 2000;43:2834-42.
40. O'Flynn K, Krensky AM, Beverley PC, Burakoff SJ, Linch DC. Phytohaemagglutinin activation of T cells through the sheep red blood cell receptor. Nature 1985;313:686-7.
41. Wingren AG, Dahlenborg K, Bjorklund M et al. Monocyte-regulated IFN-gamma production in human T cells involves CD2 signaling. J Immunol 1993;151-1328-36.
42. Mertz AK, Ugrinovic S, Lauster R et al. Characterization of the synovial T cell response to various recombinant Yersinia antigens in Yersinia enterocolitica-triggered reactive arthritis. Heat-shock protein 60 drives a major immune response. Arthritis Rheum 1998;41:315-26.
43. Rudwaleit M, Siegert S, Yin Z et al. Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism. Ann Rheum Dis 2001;60:36-42.
44. Kaufmann SH, Kaplan G. Immunity to intracellular bacteria. Res Immunol 1996;147:487-9.
45. Beatty WL, Byrne GI, Morrison RP. Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci USA 1993;90:3998-4002.
46. Beatty WL, Byrne GI, Morrison RP. Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease. Trends Microbiol 1994;2:94-8.